CME Group CME Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $6.52B+6.4% | $6.13B+9.9% | $5.58B+11.1% | $5.02B+7.0% | ||
| $2.29B+4.2% | $2.2B+2.6% | $2.14B+7.0% | $2B-2.0% | ||
| $4.23B+7.6% | $3.93B+14.4% | $3.44B+13.9% | $3.02B+14.0% | ||
| 64.9%+0.7pp | 64.1%+2.6pp | 61.6%+1.5pp | 60.1%+3.7pp | ||
| $173.4M+7.8% | $160.9M+0.9% | $159.4M-2.0% | $162.7M-2.5% | ||
| $1.1B+80.5% | $609.9M-15.0% | $717.9M+51.3% | $474.4M-34.9% | ||
| —— | —— | —— | —— | ||
| $1.26B+23.9% | $1.02B+9.5% | $927.4M+16.0% | $799.3M+8.5% | ||
| $4.07B+15.5% | $3.53B+9.3% | $3.23B+19.9% | $2.69B+2.0% | ||
| 62.5%+4.9pp | 57.5%-0.3pp | 57.8%+4.2pp | 53.6%-2.6pp | ||
| $11.16+15.4% | $9.67+9.0% | $8.87+19.9% | $7.40+1.5% | ||
| $4.34B+7.2% | $4.05B+13.6% | $3.56B+13.0% | $3.15B+12.8% | ||
| 66.5%+0.5pp | 66%+2.2pp | 63.8%+1.1pp | 62.8%+3.2pp | ||
| $4.23B+7.6% | $3.93B+14.4% | $3.44B+13.9% | $3.02B+14.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is CME Group's revenue?
- CME Group (CME) generated $6.8B in revenue over the trailing twelve months, up 7.5% year over year.
- Is CME Group profitable?
- CME Group reported $4.3B in net income over the trailing twelve months, a 63.6% net margin.
- What is CME Group's earnings per share?
- CME Group's diluted EPS over the trailing twelve months is $11.72.
- Where does CME Group's income statement data come from?
- Every line is extracted from CME Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
